| BOTHELL, Wash., May 14, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the company will be participating in the following investor conferences: - 22nd Annual Craig-Hallum Institutional Investor Conference
- May 28, 2025
- Minneapolis, MN at the Renaissance Hotel
- Benchmark 2025 Healthcare House Call Virtual Conference
- Jefferies Global Life Sciences Conference
- June 3 – 5, 2025
- New York, NY at the Marriott Marquis
- Wolfe Research Small & Mid-Cap Conference
- June 5, 2025
- New York, NY at Wolfe Headquarters
- Northland Growth Conference 2025
About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X. Media & Investor Relations At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com Investors
Alliance Advisors IR
Jody Cain
(310) 691-7100
jcain@allianceadvisors.com  View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-participate-in-upcoming-investor-conferences-in-may-and-june-2025-302454438.html
SOURCE BioLife Solutions, Inc. | |
